4.5 Article

Chimeric sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice

Journal

VACCINE
Volume 25, Issue 43, Pages 7573-7581

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2007.07.061

Keywords

encephalitis; vaccine; alphavirus

Funding

  1. NIAID NIH HHS [K08 AI059491, U54 AI057156, U54 AI057156-05] Funding Source: Medline

Ask authors/readers for more resources

We developed chimeric Sindbis (SINV)/eastern equine encephalitis (EEEV) viruses and investigated their potential for use as live virus vaccines against EEEV. One vaccine candidate contained structural protein genes from a typical North American EEEV strain, while the other had structural proteins from a naturally attenuated Brazilian isolate. Both chimeric viruses replicated efficiently in mammalian and mosquito cell cultures and were highly attenuated in mice. Vaccinated mice did not develop detectable disease or viremia, but developed high titers of neutralizing antibodies. Upon challenge with EEEV, mice vaccinated with > 10(4) PFU of the chimeric viruses were completely protected from disease. These findings support the potential use of these SIN/EEEV chimeras as safe and effective vaccines. (c) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available